sciencedaily.com/releases/2026/11/261102202829.htm Gene editing could replace a lifetime of medication, but there's a catch
In a JAMA Internal Medicine perspective, cardiologists Eric D. Smith and Venkatesh L. Murthy outline factors for weighing gene therapies for common diseases, including safety, durability and long-term monitoring. They note some existing gene therapies cost over $1 million and say affordability must be considered early.
